Terbutaline Sulfate Injection, USP
Terbutaline Sulfate Injection, USP
Terbutaline Sulfate Injection, USP
1 mg
Registration Number ANDA200122
Indications
Terbutaline sulfate injection is indicated for the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema.
product details
| Name | Terbutaline Sulfate Injection, USP |
| Registration Number | ANDA200122 |
| Generic Name | Terbutaline Sulfate |
| Territory | U.S.A. |
| Package | 1 mg/mL; 1 mL vial |
| Indication | Terbutaline sulfate injection is indicated for the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema. |
| Storage | 20-25℃ |
Adverse Reaction Contact
24 hour phone: +886-800-035-511
email : pharmacovigilance@ubi-pharma.com
Recommend
Desmopressin Acetate Injection, USP
Desmopressin Acetate Injection, USP
40 mcg/mL; 1 mL 小瓶, 10 mL 小瓶
Registration Number ANDA210223
Desmopressin Acetate Injection, USP-ampoule
Desmopressin Acetate Injection, USP-ampoule
40 mcg/mL; 1 mL ampoule
Registration Number ANDA210218
Caspofungin Acetate For Injection
Caspofungin Acetate For Injection
50 mg vial, 70 mg vial
Registration Number ANDA211263